Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,572 | 349 | 86.9% |
| Travel and Lodging | $748.24 | 1 | 9.9% |
| Education | $239.99 | 3 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,655 | 135 | $0 (2024) |
| Boston Scientific Corporation | $1,362 | 19 | $0 (2023) |
| Janssen Biotech, Inc. | $647.60 | 29 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $427.90 | 28 | $0 (2024) |
| PFIZER INC. | $287.04 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $285.33 | 16 | $0 (2024) |
| GENZYME CORPORATION | $254.53 | 13 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $253.41 | 14 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $235.04 | 15 | $0 (2024) |
| Ardelyx, Inc. | $170.61 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,854 | 91 | ABBVIE INC. ($580.43) |
| 2023 | $1,815 | 83 | AbbVie Inc. ($741.29) |
| 2022 | $941.76 | 44 | ABBVIE INC. ($440.43) |
| 2021 | $371.92 | 26 | AbbVie Inc. ($145.44) |
| 2020 | $226.00 | 16 | AbbVie Inc. ($83.45) |
| 2019 | $673.53 | 43 | AbbVie, Inc. ($226.07) |
| 2018 | $430.82 | 27 | BOSTON SCIENTIFIC CORPORATION ($157.97) |
| 2017 | $1,247 | 23 | BOSTON SCIENTIFIC CORPORATION ($884.96) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GI | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: LIVER DISEASE | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $107.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $116.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.93 | General |
| Category: GI | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 434 | 457 | $301,313 | $52,667 |
| 2022 | 17 | 623 | 672 | $495,089 | $80,188 |
| 2021 | 17 | 691 | 758 | $507,597 | $91,571 |
| 2020 | 17 | 632 | 729 | $471,176 | $76,459 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 56 | 56 | $67,690 | $9,418 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 86 | $14,678 | $6,082 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $16,224 | $5,380 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 54 | $13,522 | $5,361 | 39.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 19 | 19 | $51,204 | $4,425 | 8.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $10,344 | $3,101 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $8,106 | $2,932 | 36.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $14,934 | $2,893 | 19.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $31,600 | $2,742 | 8.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 35 | $5,760 | $2,400 | 41.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 11 | 11 | $20,294 | $2,334 | 11.5% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $15,245 | $2,324 | 15.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $10,372 | $2,198 | 21.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $21,340 | $1,077 | 5.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 88 | 88 | $110,440 | $13,076 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 91 | $21,749 | $9,756 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 132 | $21,516 | $9,566 | 44.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 38 | 38 | $106,248 | $8,404 | 7.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $27,196 | $5,346 | 19.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $14,942 | $5,101 | 34.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 65 | 65 | $52,000 | $4,823 | 9.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $13,946 | $4,613 | 33.1% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 13 | 15 | $30,090 | $3,399 | 11.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 16 | 16 | $16,736 | $3,122 | 18.7% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $18,885 | $2,695 | 14.3% |
About Eric Shen
Eric Shen is a Gastroenterology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528140076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Shen has received a total of $7,560 in payments from pharmaceutical and medical device companies, with $1,854 received in 2024. These payments were reported across 353 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,572).
As a Medicare-enrolled provider, Shen has provided services to 2,380 Medicare beneficiaries, totaling 2,616 services with total Medicare billing of $300,885. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New Brunswick, NJ
- Active Since 10/20/2006
- Last Updated 03/28/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528140076
Products in Payments
- RINVOQ (Biological) $947.04
- RESOLUTION CLIP (Device) $748.24
- SKYRIZI (Biological) $665.43
- Humira (Biological) $576.75
- STELARA (Biological) $525.73
- XIFAXAN (Drug) $343.93
- HUMIRA (Biological) $257.10
- DUPIXENT (Biological) $254.53
- Linzess (Drug) $253.41
- XELJANZ (Drug) $239.68
- ENTYVIO (Biological) $222.23
- IBSRELA (Drug) $170.61
- SPYSCOPE (Device) $135.19
- ZEPOSIA (Drug) $130.68
- EXALT Model D (Device) $121.98
- TREMFYA (Drug) $121.87
- AXIOS (Device) $113.58
- REBYOTA (Biological) $100.09
- SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) $97.13
- VOQUEZNA (Drug) $74.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New Brunswick
Dr. Vinod Rustgi, Md, MD
Gastroenterology — Payments: $555,573
Lea Chen, M.d, M.D
Gastroenterology — Payments: $179,886
Arvind Trindade, Md, MD
Gastroenterology — Payments: $91,569
George Abdelsayed, Md, MD
Gastroenterology — Payments: $43,225
Dr. Avik Sarkar, M.d, M.D
Gastroenterology — Payments: $12,779
Dr. Vishal Jain, Md, MD
Gastroenterology — Payments: $9,858